Positive staining for CD30, OCT3/4, NANOG, SOX2 GP-3, or CD30 tends to occur more commonly among embryonal carcinomas while negative staining occurs more commonly among yolk sac tumors, serving as reliable indicators between them both neoplasms. This evidence concerns the gene NANOG and yolk sac tumor.